SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Commonwealth Income & Growth Fund VII, LP – ‘10-Q’ for 3/31/22 – ‘EX-101.SCH’

On:  Wednesday, 5/18/22, at 1:41pm ET   ·   For:  3/31/22   ·   Accession #:  1654954-22-7133   ·   File #:  333-156357

Previous ‘10-Q’:  ‘10-Q’ on 11/18/21 for 9/30/21   ·   Next:  ‘10-Q’ on 9/9/22 for 6/30/22   ·   Latest:  ‘10-Q/A’ on 4/16/24 for 3/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/18/22  Commonwealth Income & Gro… VII LP 10-Q        3/31/22   52:2.1M                                   Blueprint/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    293K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
11: R1          Cover                                               HTML     67K 
12: R2          Condensed Balance Sheets                            HTML     93K 
13: R3          Condensed Balance Sheets (Parenthetical)            HTML     23K 
14: R4          Condensed Statements of Operations                  HTML     80K 
15: R5          Condensed Statements of Partners Capital            HTML     34K 
16: R6          Condensed Statements of Cash Flow (Unaudited)       HTML     39K 
17: R7          Business                                            HTML     20K 
18: R8          Summary of Significant Accounting Policies          HTML     30K 
19: R9          Information Technology Medical Technology           HTML     44K 
                Telecommunications Technology Inventory Management               
                Equipment (Equipment)                                            
20: R10         Investment in COF 2                                 HTML     27K 
21: R11         Related Party Transactions                          HTML     35K 
22: R12         Notes Payable                                       HTML     31K 
23: R13         Supplemental Cash Flow Information                  HTML     22K 
24: R14         Commitments and Contingencies                       HTML     28K 
25: R15         Summary of Significant Accounting Policies          HTML     38K 
                (Policies)                                                       
26: R16         Summary of Significant Accounting Policies          HTML     20K 
                (Tables)                                                         
27: R17         Information Technology Medical Technology           HTML     41K 
                Telecommunications Technology Inventory Management               
                Equipment (Tables)                                               
28: R18         Investment in COF 2 (Tables)                        HTML     26K 
29: R19         Related Party Transactions (Tables)                 HTML     33K 
30: R20         Notes Payable (Tables)                              HTML     27K 
31: R21         Supplemental Cash Flow Information (Tables)         HTML     20K 
32: R22         Business (Details Narrative)                        HTML     25K 
33: R23         Summary of Significant Accounting Policies          HTML     22K 
                (Details)                                                        
34: R24         Summary of Significant Accounting Policies          HTML     21K 
                (Details Narrative)                                              
35: R25         Information Technology Medical Technology           HTML     28K 
                Telecommunications Technology Inventory Management               
                Equipment (Details)                                              
36: R26         Information Technology Medical Technology           HTML     22K 
                Telecommunications Technology Inventory Management               
                Equipment (Details 1)                                            
37: R27         Information Technology Medical Technology           HTML     24K 
                Telecommunications Technology Inventory Management               
                Equipment (Details 2)                                            
38: R28         Information Technology Medical Technology           HTML     25K 
                Telecommunications Technology Inventory Management               
                Equipment (Details 3)                                            
39: R29         Information Technology Medical Technology           HTML     24K 
                Telecommunications Technology Inventory Management               
                Equipment (Details Narrative)                                    
40: R30         Investment in COF 2 (Details)                       HTML     26K 
41: R31         Investment in COF 2 (Details Narrative)             HTML     27K 
42: R32         Related Party Transactions (Details)                HTML     25K 
43: R33         Notes Payable (Details)                             HTML     27K 
44: R34         Notes Payable (Details 1)                           HTML     28K 
45: R35         Notes Payable (Details Narrative)                   HTML     17K 
46: R36         Supplemental Cash Flow Information (Details)        HTML     18K 
47: R37         Commitments and Contingencies (Details Narrative)   HTML     31K 
50: XML         IDEA XML File -- Filing Summary                      XML     89K 
48: XML         XBRL Instance -- cigf_10q_htm                        XML    379K 
49: EXCEL       IDEA Workbook of Financial Reports                  XLSX     50K 
 8: EX-101.CAL  XBRL Calculations -- cigf7-20220331_cal              XML     90K 
10: EX-101.DEF  XBRL Definitions -- cigf7-20220331_def               XML    101K 
 7: EX-101.LAB  XBRL Labels -- cigf7-20220331_lab                    XML    401K 
 9: EX-101.PRE  XBRL Presentations -- cigf7-20220331_pre             XML    294K 
 6: EX-101.SCH  XBRL Schema -- cigf7-20220331                        XSD    101K 
51: JSON        XBRL Instance as JSON Data -- MetaLinks              174±   224K 
52: ZIP         XBRL Zipped Folder -- 0001654954-22-007133-xbrl      Zip     74K 


‘EX-101.SCH’   —   XBRL Schema — cigf7-20220331


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="yes" encoding="windows-1252"?>
<!-- XBRL Document Created with XBRLMaster -->
<!-- Version: 2.3.08 -->
<!-- Based on XBRL 2.1 -->
<!-- Date of creation: 05/18/2022 -->
<!-- Software architectural design and coding: A'c Dharmapremananda Avt. -->
<!-- Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved. -->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:cigf7="http://cigf7.com/20220331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cigf7.com/20220331">
<annotation>
<appinfo>
<link:roleType roleURI="http://cigf7.com/role/Cover" id="Cover">
<link:definition> 000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CondensedBalanceSheets" id="CondensedBalanceSheets">
<link:definition> 000002 - Statement - Condensed Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CondensedBalanceSheetsParenthetical" id="CondensedBalanceSheetsParenthetical">
<link:definition> 000003 - Statement - Condensed Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CondensedStatementsOfOperations" id="CondensedStatementsOfOperations">
<link:definition> 000004 - Statement - Condensed Statements of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CondensedStatementsOfPartnersCapital" id="CondensedStatementsOfPartnersCapital">
<link:definition> 000005 - Statement - Condensed Statements of Partners Capital </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CondensedStatementsOfCashFlowUnaudited" id="CondensedStatementsOfCashFlowUnaudited">
<link:definition> 000006 - Statement - Condensed Statements of Cash Flow (unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/Business" id="Business">
<link:definition> 000007 - Disclosure - Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 000008 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentEquipment" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentEquipment">
<link:definition> 000009 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Equipment) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InvestmentInCof2" id="InvestmentInCof2">
<link:definition> 000010 - Disclosure - Investment in COF 2 </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition> 000011 - Disclosure - Related Party Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/NotesPayable" id="NotesPayable">
<link:definition> 000012 - Disclosure - Notes Payable </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
<link:definition> 000013 - Disclosure - Supplemental Cash Flow Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 000014 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 000015 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition> 000016 - Disclosure - Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentTables" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentTables">
<link:definition> 000017 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InvestmentInCof2Tables" id="InvestmentInCof2Tables">
<link:definition> 000018 - Disclosure - Investment in COF 2 (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
<link:definition> 000019 - Disclosure - Related Party Transactions (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/NotesPayableTables" id="NotesPayableTables">
<link:definition> 000020 - Disclosure - Notes Payable (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SupplementalCashFlowInformationTables" id="SupplementalCashFlowInformationTables">
<link:definition> 000021 - Disclosure - Supplemental Cash Flow Information (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/BusinessDetailsNarrative" id="BusinessDetailsNarrative">
<link:definition> 000022 - Disclosure - Business (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
<link:definition> 000023 - Disclosure - Summary of Significant Accounting Policies (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails">
<link:definition> 000025 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails1" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails1">
<link:definition> 000026 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails2" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails2">
<link:definition> 000027 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails3" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetails3">
<link:definition> 000028 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Details 3) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetailsNarrative" id="InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentDetailsNarrative">
<link:definition> 000029 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InvestmentInCof2Details" id="InvestmentInCof2Details">
<link:definition> 000030 - Disclosure - Investment in COF 2 (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/InvestmentInCof2DetailsNarrative" id="InvestmentInCof2DetailsNarrative">
<link:definition> 000031 - Disclosure - Investment in COF 2 (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
<link:definition> 000032 - Disclosure - Related Party Transactions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/NotesPayableDetails" id="NotesPayableDetails">
<link:definition> 000033 - Disclosure - Notes Payable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/NotesPayableDetails1" id="NotesPayableDetails1">
<link:definition> 000034 - Disclosure - Notes Payable (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
<link:definition> 000035 - Disclosure - Notes Payable (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/SupplementalCashFlowInformationDetails" id="SupplementalCashFlowInformationDetails">
<link:definition> 000036 - Disclosure - Supplemental Cash Flow Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cigf7.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
<link:definition> 000037 - Disclosure - Commitments and Contingencies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="cigf7-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cigf7-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cigf7-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cigf7-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<import namespace="http://fasb.org/srt-roles/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd"/>
<import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<import namespace="http://fasb.org/us-roles/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"/>
<import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
<import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
<element id="cigf7_LiabilitiesAndPartnersCapitalAbstract" name="LiabilitiesAndPartnersCapitalAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_LiabilitiesAndPartnersCapital" name="LiabilitiesAndPartnersCapital" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_AccountPayableAndOtherAccruedLiabilities" name="AccountPayableAndOtherAccruedLiabilities" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_OtherReceivablesReserve" name="OtherReceivablesReserve" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_SalesAndPropertyTaxesRevenue" name="SalesAndPropertyTaxesRevenue" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_SalesAndPropertyTaxes" name="SalesAndPropertyTaxes" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_Redemptionsamount" name="Redemptionsamount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_ScheduleOfNetInvestmentInDirectFinancingLeasesTextBlock" name="ScheduleOfNetInvestmentInDirectFinancingLeasesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_FinanceLeaseRiskLevelTextBlock" name="FinanceLeaseRiskLevelTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_OfferedSaleShares" name="OfferedSaleShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_UnitSold" name="UnitSold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_OriginalMaturityTerms" name="OriginalMaturityTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_CashAndCashEquivalentsAggregateBalance" name="CashAndCashEquivalentsAggregateBalance" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_MinimumLeasePaymentsFinanceLeases" name="MinimumLeasePaymentsFinanceLeases" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_ResidualValueFinanceLeases" name="ResidualValueFinanceLeases" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_InitialDirectCostsFinanceLeases" name="InitialDirectCostsFinanceLeases" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_NetInvestmentInFinanceLeases" name="NetInvestmentInFinanceLeases" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_RiskLevelLow" name="RiskLevelLow" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_RiskLevelModerateLow" name="RiskLevelModerateLow" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_RiskLevelModerate" name="RiskLevelModerate" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_RiskLevelModerateHigh" name="RiskLevelModerateHigh" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_RiskLevelHigh" name="RiskLevelHigh" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_TotalRiskLevel" name="TotalRiskLevel" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquipmentShared" name="EquipmentShared" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_DebtShared" name="DebtShared" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_TotalSharedEquipment" name="TotalSharedEquipment" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_TotalDebtShared" name="TotalDebtShared" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_DescriptionOfCreditExtend" name="DescriptionOfCreditExtend" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquityMethodInvestmentsSummarizedFinancialInformationAssets" name="EquityMethodInvestmentsSummarizedFinancialInformationAssets" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquityMethodInvestmentsSummarizedFinancialInformationLiabilities" name="EquityMethodInvestmentsSummarizedFinancialInformationLiabilities" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquityMethodInvestmentsSummarizedFinancialInformationEquityOrCapital" name="EquityMethodInvestmentsSummarizedFinancialInformationEquityOrCapital" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquityMethodInvestmentsSummarizedFinancialInformationRevenue" name="EquityMethodInvestmentsSummarizedFinancialInformationRevenue" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquityMethodInvestmentsSummarizedFinancialInformationCostOfSales" name="EquityMethodInvestmentsSummarizedFinancialInformationCostOfSales" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquityMethodInvestmentsSummarizedFinancialInformationNetIncomeLoss" name="EquityMethodInvestmentsSummarizedFinancialInformationNetIncomeLoss" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_CommonwealthOpportunityFund" name="CommonwealthOpportunityFund" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_DistributionsToThePartnershipWasPaidRecordedAsAReceivableFromCof2" name="DistributionsToThePartnershipWasPaidRecordedAsAReceivableFromCof2" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_DistributionsToThePartnershipWasPaid" name="DistributionsToThePartnershipWasPaid" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_ReimbursableExpenses" name="ReimbursableExpenses" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquipmentAcquisitionFees" name="EquipmentAcquisitionFees" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_DebtPlacementFees" name="DebtPlacementFees" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquipmentManagementFees" name="EquipmentManagementFees" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_EquipmentLiquidationFee" name="EquipmentLiquidationFee" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_PartnershipInterestAndDistribution" name="PartnershipInterestAndDistribution" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_LeaseRevenueNetOfInterestExpenseOnNotesPayableRealizedAsAResultOfDirectPaymentOfPrincipalByLesseeToBank" name="LeaseRevenueNetOfInterestExpenseOnNotesPayableRealizedAsAResultOfDirectPaymentOfPrincipalByLesseeToBank" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_DescriptionOfListOfItem" name="DescriptionOfListOfItem" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_QuestionedExpense" name="QuestionedExpense" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="cigf7_CommitmentsAndContingenciesabstract" name="CommitmentsAndContingenciesabstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element name="GeneralPartnerUnitsMember" id="cigf7_GeneralPartnerUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element name="LimitedPartnerUnitsMember" id="cigf7_LimitedPartnerUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element name="GeneralPartnersMember" id="cigf7_GeneralPartnersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element name="LimitedPartnersMember" id="cigf7_LimitedPartnersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element name="FundTwoMember" id="cigf7_FundTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element name="Note2Member" id="cigf7_Note2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element name="Note3Member" id="cigf7_Note3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
</schema>

Top
Filing Submission 0001654954-22-007133   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 3:17:11.1am ET